References
- Engelhart E., Loewi O. Arch. Exptl. Pathol. Pharmakol. Naunyn-Schmiedeberg's (1930); 150: 1
- Koelle G. B. Anticholinesterase Agents. The Pharmacological Basis of Therapeutics. 4th Ed., L. S. Goodman, A Gilman. The MacMillan Co., Toronto, CA (1970); 442–465
- Thal L. J., Masur D. M., Sharpless N. S., Fuld P. A., Davies P. Prog. Neuropsychopharmacol. Biol. Psychiatry (England) (1986); 10: 627–636
- Mohs R. C., Davis B. M., Johns C. A., Mathe A. A., Greenwald B. S., Horvath T. B., Davis K. L. Am. J. Psychiatry (1985); 142: 28–33
- Nutt J. G. Neurology (1983); 33: 932–935
- Walker M. B. Lancet (1934); 1: 1200–1201
- VerVoort S. M. Urology (1987); 29: 282–289
- Rupreht J., Dworacek B., Oosthoek H., Dzoljic M. R., Valkenburg M. J. Toxicol. Clin. Toxicol. (1983); 21: 387–397
- Pedersen J. E. Ugeskr Laeger (1985); 147: 3586–3587
- Beilin B., Vatashsky E., Weinstock M. Brit. J. Clin. Pract. (1985); 31: 400–401
- Koster R. J. Pharmacol. Exp. Ther. (1946); 88: 39–46
- Fleisher J. H., Harris L. W. Biochem. Pharmacol. (1965); 14: 641–650
- Berry W. K., Davies D. R. Biochem. Pharmacol. (1970); 19: 927–934
- Harris L. W., Talbot B. G., Lennox W. J., Anderson D. R. Proc. Sixth Med. (1987); 693–696, Chem. Def. Biosci. Rev. U.S. Army MRICD, Aberdeen Proving Ground MD 21010-5425
- Harris L., Talbot W., Anderson D., Green M., Jones D., Koplovitz I. The Pharmacologist (1986); 28: 131
- Harris L. W., Anderson D. R., Lennox W. J., Woodard C. L., Pastelak A. M., Vanderpool B. A. Biochem. Pharmacol. (1990); 40: 2677–2682
- Bliss C. I. Statistics in Biology. McGraw-Hill Book Company, N.Y. (1967); Vol 1: 439, 408–412
- Natrella M. G. Experimental Statistics. Handbook 91U.S. Department of Commerce, National Bureau of Standards. U.S. Government Printing Office, Washington, D.C. (1963); 21-1–21-6
- Harris L. W., Talbot B. G., Lennox W. J., Anderson D. R., Solana R. P. Drug Chem. Toxicol (1991), in press
- Bliss C. I. Statistics in Biology. McGraw-Hill Book Company, N.Y. (1967); Vol 1: 62–65
- Talbot B. G., Anderson D. R., Harris L. W., Yarbrough L. W., Lennox W. J. Drug Chem. Toxicol. (1988); 11: 289–305
- Saunders B., Price R. M. NBC Defense and Technology (1986); 1: 36–39
- Reiner E. Bull. Wld. Hlth. Org. (1971); 44: 109–112
- Yu Q. S., Atack J. R., Rapoport S. I., Brossi A. FEBS Letters (1988); 234: 127–130
- Bores G. M., Huber F. P., Hamer R. R.L., Helsley G. C., Ellis D. B. FASEB (1989); 3: A892
- Atack J. R., Yu Q. S., Soncrant T. T., Brossi A., Rapoport S. I. J. Pharmacol. Exp. Ther. (1989); 249: 194
- Lieske C. N., Gepp R. T., Clark J. H., Meyer H. G., Blumbergs P., Tseng C. C. J. Enzyme Inhib (1990), submitted
- Lennox W. J., Harris L. W., Talbot B. G., Anderson D. R. Life Sci. (1985); 21: 793–798
- Maxwell D. M., Brecht K. M., Lenz D. E., O'Neill B. L. J. Pharm. Exp. Ther. (1988); 246: 986–991
- Harris L. W., Stitcher D. L., Heyl W. C. Life Sci. (1980); 26: 1885–1891
- Harris L. W., Talbot B. G., Anderson D. R., Lennox W. J., Green M. D. The Pharmacologist (1985); 22: 134
- Dirnhuber P., French M. C., Green D. M., Leadbeater L., Stratton J. A. J. Pharm. Pharmacol. (1979); 31: 295–299